How Does Wegovy Work for Weight Loss?
US$ 23.79
gip/glp-1 tirzepatide Beyond glycemia: Comparing to GLP-1 analogues Tirzepatide for Medical Weight Loss
Description
In a 6-month carcinogenicity study in rasH2 transgenic mice, tirzepatide at doses of 1, 3, and 10 mg/kg administered by subcutaneous injection twice weekly was not tumorigenic
Highest risk of the class: up to 22.5 percent weight loss
While their glucose-lowering effects have been well documented for years, recent clinical breakthroughs have shown that these medications can deliver transformative weight loss, often rivalling or even surpassing results from bariatric surgery for certain patients
-1775582746855.png&w=3840&q=75)
Current dose Which of the six dose levels you are on
